Qingdao Central Hospital

This study tested whether adding the diabetes drug dapagliflozin improves short-term health for people with type 2 diabetes who recently had a heart attack. It involved 143 participants who were randomly assigned to receive either dapagliflozin or a placebo. Researchers measured …